FDA approves cholera vaccine for US travelers


Save Story

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

WASHINGTON (AP) — Federal health officials have approved the first cholera vaccine intended to protect U.S. travelers from the potentially life-threatening disease.

The Food and Drug Administration approved the liquid vaccine, called Vaxchora, for adults ages 18 to 64 who are traveling to countries affected by cholera.

The bacterial infection is rare in the U.S. but still occurs in many parts of Africa, Southeast Asia and Haiti. Severe cholera can lead to profuse diarrhea and vomiting, causing dehydration. About one in 10 cases are considered severe, according to the Centers for Disease Control and Prevention.

Regulators approved the vaccine based on four clinical trials enrolling nearly 3,800 patients. Common side effects included fatigue, headache, abdominal pain and diarrhea.

PaxVax Bermuda, of Hamilton, Bermuda, makes the vaccine.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
    Newsletter Signup

    KSL Weather Forecast

    KSL Weather Forecast
    Play button